[
  {
    "ts": null,
    "headline": "Amgen Inc. stock rises Tuesday, still underperforms market",
    "summary": "Amgen Inc. stock rises Tuesday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=4660d80f6baf659c281d46427aeb14ae3824182679189d356e8c7e81cad9774b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745339640,
      "headline": "Amgen Inc. stock rises Tuesday, still underperforms market",
      "id": 134054548,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock rises Tuesday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=4660d80f6baf659c281d46427aeb14ae3824182679189d356e8c7e81cad9774b"
    }
  },
  {
    "ts": null,
    "headline": "3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold",
    "summary": "When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.  Three Fool.com contributors believe they've identified relatively safe growth stocks in the healthcare sector that you can buy and hold.  Here's why they picked Amgen (NASDAQ: AMGN), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX).",
    "url": "https://finnhub.io/api/news?id=53c5b17920fda4f31948747fce1f9dbe0959aeee07b477b2a769b41bc9954da4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745329980,
      "headline": "3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold",
      "id": 134038730,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.  Three Fool.com contributors believe they've identified relatively safe growth stocks in the healthcare sector that you can buy and hold.  Here's why they picked Amgen (NASDAQ: AMGN), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX).",
      "url": "https://finnhub.io/api/news?id=53c5b17920fda4f31948747fce1f9dbe0959aeee07b477b2a769b41bc9954da4"
    }
  },
  {
    "ts": null,
    "headline": "Is Amgen Inc. (AMGN) a Cheap NASDAQ Stock to Buy According to Hedge Funds?",
    "summary": "We recently published a list of the 11 Cheap NASDAQ Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other cheap NASDAQ stocks. On April 10, Dan Ives, Head of Global Tech Research at Wedbush Securities, appeared on an interview […]",
    "url": "https://finnhub.io/api/news?id=094f283d68a9c4a4539bb50f8e1cae0ca80cb93bfdaafd9ef00ba0e42b3b6588",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745329774,
      "headline": "Is Amgen Inc. (AMGN) a Cheap NASDAQ Stock to Buy According to Hedge Funds?",
      "id": 134038982,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "We recently published a list of the 11 Cheap NASDAQ Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other cheap NASDAQ stocks. On April 10, Dan Ives, Head of Global Tech Research at Wedbush Securities, appeared on an interview […]",
      "url": "https://finnhub.io/api/news?id=094f283d68a9c4a4539bb50f8e1cae0ca80cb93bfdaafd9ef00ba0e42b3b6588"
    }
  },
  {
    "ts": null,
    "headline": "Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy",
    "summary": "Investing.com -- Cantor Fitzgerald initiated or transferred coverage on 10 large-cap U.S. biopharma stocks in a note Tuesday, highlighting a selective approach that favors dominant franchises with strong growth visibility and limited exposure to policy headwinds.",
    "url": "https://finnhub.io/api/news?id=fb797e9d859b02cce2cfd30df698c57a5a3a2d8623dade1fe4a1f6047414ee40",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745329681,
      "headline": "Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy",
      "id": 134038510,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Investing.com -- Cantor Fitzgerald initiated or transferred coverage on 10 large-cap U.S. biopharma stocks in a note Tuesday, highlighting a selective approach that favors dominant franchises with strong growth visibility and limited exposure to policy headwinds.",
      "url": "https://finnhub.io/api/news?id=fb797e9d859b02cce2cfd30df698c57a5a3a2d8623dade1fe4a1f6047414ee40"
    }
  }
]